Delivery Order SPE2DR25D9318-SPE2DR26FSLD0
- Not listed
- The Defense Logistics Agency awarded a $111,352 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 6, 2025, with an ultimate completion date of December 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency awarded a $1,113.52 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The contract, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, utilizes firm fixed-price pricing with no set-aside designation, allowing the vendor to compete on an unrestricted basis. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,350.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (Yellow Fever Vaccine) in one-dose vials. The contract, issued on July 11, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite...
- The Defense Logistics Agency issued a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) dose vials on December 4, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 26, 2025, represents a routine pharmaceutical procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating competitive procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award represents one...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $13,516.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for yellow fever vaccine (YF-VAX) products. The delivery order, awarded on November 18, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through unrestricted competition. The delivery order...
- SPE2DR25D9318Indefinite Delivery Contract
- SPE2DR25D9318-SPE2DR26FSLD0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,351.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The order was placed on December 5, 2025, with an ultimate completion date of December 29, 2025, under firm fixed-price terms with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a critical pharmaceutical supplier for Department of Defense healthcare operations. The PPV-G GEN V represents a significant modernization of the Department of Defense's pharmaceutical supply chain, with DMS Pharmaceutical Group serving as one of multiple regional prime vendor contractors within the broader $30.3 billion acquisition strategy. The underlying indefinite delivery contract, designated SPE2DR and running through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 12/4/25 |